IGF1R and breast carcinoma: For example, we demonstrated the benefits of ligand neutralization by IGFBP-1 in model systems.29 More recently ligand neutralizing mAb such as MEDI-57330 have been show to decrease the tumorigenic behavior of IGF-1R positive breast cancer.